Replies to post #64238 on Anavex Life Sciences Corp (AVXL)

[jimmy667]

Jazz tendered offer for junior clinical stage cancer biotech Celator Pharmaceuticals Inc for 2.2 Bil a 70% premium to previous market price. It has a drug in Ph 3 for Colo-rectal cancer. Many junior bio-techs seem to be very undervalued in this market. It has 42 mil shares outstanding. Do your own math but mine equates to a geometrically larger market cap for AVXL in a geometrically larger indication.

Do not blame George he is just early!
Hold on to your shares and move in the boats.

JMHO opinion.
Go Anavex Life Sciences